(Q50531560)

14 March 2018

title

Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production (English)

1 reference

14 March 2018

author name string

Yosuke Saka

1

1 reference

14 March 2018

Kazuhiro Furuhashi

2

1 reference

14 March 2018

Takayuki Katsuno

3

1 reference

14 March 2018

Hangsoo Kim

4

1 reference

14 March 2018

Takenori Ozaki

5

1 reference

14 March 2018

Kenta Iwasaki

6

1 reference

14 March 2018

Masataka Haneda

7

1 reference

14 March 2018

Waichi Sato

8

1 reference

14 March 2018

Naotake Tsuboi

9

1 reference

14 March 2018

Yasuhiko Ito

10

1 reference

14 March 2018

Seiichi Matsuo

11

1 reference

14 March 2018

Takaaki Kobayashi

12

1 reference

14 March 2018

Shoichi Maruyama

13

1 reference

14 March 2018

publication date

1 May 2011

1 reference

14 March 2018

published in

Xenotransplantation

1 reference

14 March 2018

volume

18

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

196-208

1 reference

14 March 2018

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cell therapy: Two steps forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Immunophenotype characterization of rat mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Mesenchymal stem cells suppress B-cell terminal differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3089.2011.00640.X

10.1111/J.1399-3089.2011.00640.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018